These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14973970)

  • 21. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
    Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
    Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2 months.
    Ziv O; Adelson D; Sadeh R; Kordeluk S; El-Saied S; Leibovitz E; Kraus M; Kaplan D
    Eur J Pediatr; 2023 Jun; 182(6):2873-2879. PubMed ID: 37052673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.
    Lucero MG; Dulalia VE; Parreno RN; Lim-Quianzon DM; Nohynek H; Makela H; Williams G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004977. PubMed ID: 15495133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
    Delgleize E; Leeuwenkamp O; Theodorou E; Van de Velde N
    BMJ Open; 2016 Nov; 6(11):e010776. PubMed ID: 27903558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal vaccines for sickle cell disease.
    Davies EG; Riddington C; Lottenberg R; Dower N
    Cochrane Database Syst Rev; 2004; (1):CD003885. PubMed ID: 14974042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does pneumococcal conjugate vaccination affect onset and risk of first acute otitis media and recurrences? A primary care-based cohort study.
    Fortanier AC; Venekamp RP; Hoes AW; Schilder AGM
    Vaccine; 2019 Mar; 37(11):1528-1532. PubMed ID: 30738648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age.
    Lucero MG; Dulalia VE; Nillos LT; Williams G; Parreño RA; Nohynek H; Riley ID; Makela H
    Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD004977. PubMed ID: 19821336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine.
    Harrison CJ
    Pediatr Infect Dis J; 2003 Aug; 22(8 Suppl):S120-30. PubMed ID: 14566998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute otitis media and pneumococcal vaccination - an observational cross-sectional study of otitis media among vaccinated and unvaccinated children in Greenland.
    Jespersen SI; Demant MN; Pedersen ML; Homøe P
    Int J Circumpolar Health; 2021 Dec; 80(1):1858615. PubMed ID: 33407056
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
    Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
    Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xylitol for preventing acute otitis media in children up to 12 years of age.
    Azarpazhooh A; Lawrence HP; Shah PS
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007095. PubMed ID: 27486835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study.
    Cohen R; Martin E; de La Rocque F; Thollot F; Pecquet S; Werner A; Boucherat M; Varon E; Bingen E; Levy C
    Pediatr Infect Dis J; 2013 Aug; 32(8):810-4. PubMed ID: 23429555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine.
    Brunton S
    Clin Ther; 2006 Jan; 28(1):118-23. PubMed ID: 16490585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-Effectiveness Comparison of Pneumococcal Conjugate Vaccines in Turkish Children.
    Marijam A; Olbrecht J; Ozakay A; Eken V; Meszaros K
    Value Health Reg Issues; 2019 Sep; 19():34-44. PubMed ID: 30776766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of acute otitis media, pneumonia, and invasive pneumococcal disease in children in the United States after the introduction of 13-valent pneumococcal conjugate vaccines during 2014-2018.
    Hu T; Song Y; Done N; Mohanty S; Liu Q; Sarpong EM; Lemus-Wirtz E; Signorovitch J; Weiss T
    BMC Health Serv Res; 2023 Apr; 23(1):398. PubMed ID: 37098521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Pneumococcal Vaccines on Otitis Media in Children: A Systematic Review.
    Marra LP; Sartori AL; Martinez-Silveira MS; Toscano CM; Andrade AL
    Value Health; 2022 Jun; 25(6):1042-1056. PubMed ID: 35667776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in pneumococcal vaccination of children.
    Russell FM; Mulholland EK
    Ann Trop Paediatr; 2004 Dec; 24(4):283-94. PubMed ID: 15720885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.
    Teele DW; Klein JO; Bratton L; Fisch GR; Mathieu OR; Porter PJ; Starobin SG; Tarlin LD; Younes RP
    Rev Infect Dis; 1981; 3 Suppl():S113-8. PubMed ID: 7280443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.
    Zhang XH; Leeuwenkamp O; Oh KB; Lee YE; Kim CM
    Hum Vaccin Immunother; 2018 Jan; 14(1):85-94. PubMed ID: 29115905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.